Welcome to The Visible Embryo
Home-- -History-- -Bibliography- -Pregnancy Timeline- --Prescription Drugs in Pregnancy- -- Pregnancy Calculator- --Female Reproductive System- -Contact
 

Welcome to The Visible Embryo, a comprehensive educational resource on human development from conception to birth.

The Visible Embryo provides visual references for changes in fetal development throughout pregnancy and can be navigated via fetal development or maternal changes.

The National Institutes of Child Health and Human Development awarded Phase I and Phase II Small Business Innovative Research Grants to develop The Visible Embryo. Initally designed to evaluate the internet as a teaching tool for first year medical students, The Visible Embryo is linked to over 600 educational institutions and is viewed by more than one million visitors each month.

Today, The Visible Embryo is linked to over 600 educational institutions and is viewed by more than 1 million visitors each month. The field of early embryology has grown to include the identification of the stem cell as not only critical to organogenesis in the embryo, but equally critical to organ function and repair in the adult human. The identification and understanding of genetic malfunction, inflammatory responses, and the progression in chronic disease, begins with a grounding in primary cellular and systemic functions manifested in the study of the early embryo.

WHO International Clinical Trials Registry Platform


The World Health Organization (WHO) has created a new Web site to help researchers, doctors and
patients obtain reliable information on high-quality clinical trials. Now you can go to one website and search all registers to identify clinical trial research underway around the world!





Home

History

Bibliography

Pregnancy Timeline

Prescription Drug Effects on Pregnancy

Pregnancy Calculator

Female Reproductive System

Contact The Visible Embryo

News Alerts Archive

Disclaimer: The Visible Embryo web site is provided for your general information only. The information contained on this site should not be treated as a substitute for medical, legal or other professional advice. Neither is The Visible Embryo responsible or liable for the contents of any websites of third parties which are listed on this site.
Content protected under a Creative Commons License.

No dirivative works may be made or used for commercial purposes.

 

Pregnancy Timeline by SemestersFetal liver is producing blood cellsHead may position into pelvisBrain convolutions beginFull TermWhite fat begins to be madeWhite fat begins to be madeHead may position into pelvisImmune system beginningImmune system beginningPeriod of rapid brain growthBrain convolutions beginLungs begin to produce surfactantSensory brain waves begin to activateSensory brain waves begin to activateInner Ear Bones HardenBone marrow starts making blood cellsBone marrow starts making blood cellsBrown fat surrounds lymphatic systemFetal sexual organs visibleFinger and toe prints appearFinger and toe prints appearHeartbeat can be detectedHeartbeat can be detectedBasic Brain Structure in PlaceThe Appearance of SomitesFirst Detectable Brain WavesA Four Chambered HeartBeginning Cerebral HemispheresFemale Reproductive SystemEnd of Embryonic PeriodEnd of Embryonic PeriodFirst Thin Layer of Skin AppearsThird TrimesterSecond TrimesterFirst TrimesterFertilizationDevelopmental Timeline
CLICK ON weeks 0 - 40 and follow along every 2 weeks of fetal development
Google Search artcles published since 2007
 
 

Home | Pregnancy Timeline | News Alerts |News Archive Dec 3, 2014

The highest rate of SGA occurred in pregnancies where no folate was taken, with 16.3% 
of babies being born under the 10th percentile and 8.9% under the 5th percentile.

Image source: Pair of Docs

 






 

 

Folic acid before pregnancy reduces SGA babies

Taking folic acid before conception significantly reduces the risk of small for gestational age (SGA) babies at birth.

This United Kingdom (UK) population-based study is published in An International Journal of Obstetrics and Gynaecology (BJOG). The study assesses the affects of taking folic acid supplements before and during pregnancy to evaluate the risk to a baby being SGA at birth. Small for gestational age (SGA) babies are defined as having a birth weight in the lowest 10% of babies born.

Being small for gestational age is associated with increased neonatal morbidity and an increased risk of chronic disease in later life such as diabetes, hypertension, obesity, cardiovascular disease and mental health problems.


Folic acid supplements have already been shown to reduce the risk of neural tube defects, such as spina bifida, and is recommended in the UK for women prior to conception.

However, uptake is low in women of child bearing age state the authors, and previous studies have suggested pre-conception use is between 14.8% and 31%, with lower use in younger ages and in ethnic minorities.


The total study population represented a diverse group of women, mean age at pregnancy of 28.7 years, a median BMI of 24.7 and 42% being first time mothers. The majority of women were non-smokers (81.7%).

Of 108,525 pregnancies with information on folic acid supplements, 84.9% had taken folic acid during pregnancy. Commencing the supplement was recorded in 39,416 pregnancies, of which 25.5% of women took it before conception.


Results show that the overall proportion of babies with a birth weight under the 10th percentile was 13.4% and under the 5th percentile was 7%. The highest rate of SGA births occurred in pregnancies where no folate was taken, with 16.3% under the 10th percentile and 8.9% under the 5th percentile.

In pre-conceptile women the prevalence of birth weight lower than the 10th percentile was 9.9% while that of birth weight under the 5th centile was 4.8%.

And in women taking folic acid post-conceptually, birth weight lower than the 10th percentile was 13.8%, while that of birth weight under the 5th centile was 7.1%.


The authors conclude that although folic acid supplements are a standard recommendation in the UK, the policy is poorly followed and strategies are needed to increase uptake. Further research is needed to find out how folic acid supplements produce such a positive result on birth weight and how much the dose of supplements can be increased in women at high risk of SGA, state the authors.


"Increased uptake of folic acid prior to pregnancy and throughout the first trimester could have significant public health benefits given the poor outcomes associated with SGA babies. New strategies are therefore vital to improve the lives of both mothers and babies."

Khaled Ismail, Professor of Obstetrics and Gynaecology, University of Birmingham, co-author of the study.


Abstract
Results
Of 108 525 pregnancies with information about FA supplementation, 92 133 (84.9%) had taken FA during pregnancy. Time of commencement of supplementation was recorded in 39 416 pregnancies, of which FA was commenced before conception in 10 036, (25.5%) cases. Preconception commencement of FA supplementation was associated with reduced risk of SGA <10th centile (aOR 0.80, 95% CI 0.71–0.90, P < 0.01) and SGA <5th centile (aOR 0.78, 95% CI 0.66–0.91, P < 0.01). This result was reproduced when the data were pooled with other studies in the systematic review, showing a significant reduction in SGA (<5th centile) births with preconception commencement of FA (aOR 0.75, 95% CI 0.61–0.92, P < 0.006). In contrast, postconception folate had no significant effect on SGA rates.

Conclusion
Supplementation with FA significantly reduces the risk of SGA at birth but only if commenced preconceptually independent of other risk factors.

Reference
Hodgetts VA, Morris RK, Francis A, Gardosi J, Ismail KM. Effectiveness of folic acid supplementation in pregnancy on reducing the risk of small for gestational age neonates: A population study, systematic review and meta-analysis. BJOG 2014; http://dx.doi.org/10.1111/1471-0528.13202

http://www.eurekalert.org/pub_releases/2014-11/w-nse112514.php

Return to top of page